Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)

Bauckneht, Matteo; Lanfranchi, Francesco; Albano, Domenico; Triggiani, Luca; Linguanti, Flavia; Urso, Luca; Mazzola, Rosario; Rizzo, Alessio; D’Angelo, Elisa; Dondi, Francesco; Mataj, Eneida; Pedersoli, Gloria; Abenavoli, Elisabetta Maria; Vaggelli, Luca; Detti, Beatrice; Ortolan, Naima; Malorgio, Antonio; Guarneri, Alessia; Garrou, Federico; Fiorini, Matilde; Grimaldi, Serena; Ghedini, Pietro; Iorio, Giuseppe Carlo; Iudicello, Antonella; Rovera, Guido; Fornarini, Giuseppe; Bongiovanni, Diego; Marcenaro, Michela; Pazienza, Filippo Maria; Timon, Giorgia; Salgarello, Matteo; Racca, Manuela; Bartolomei, Mirco; Panareo, Stefano; Ricardi, Umberto; Bertagna, Francesco; Alongi, Filippo; Barra, Salvina; Morbelli, Silvia; Sambuceti, Gianmario; Belgioia, Liliana

doi:10.2967/jnumed.124.267586

J Nucl Med

2024

DOI: 10.2967/jnumed.124.267586

|View full text |Cite

Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)

Matteo Bauckneht,

Francesco Lanfranchi,

Domenico Albano

et al.

Abstract: Visual Abstract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

PSMA PET/CT in staging recurrent prostate cancer: a viewfinder, not a compass

Bauckneht,

Laudicella,

Lanfranchi

et al. 2024

Eur Radiol

View full text Add to dashboard Cite

PSMA PET/CT in staging recurrent prostate cancer: a viewfinder, not a compass

Bauckneht,

Laudicella,

Lanfranchi

et al. 2024

Eur Radiol

View full text Add to dashboard Cite

MDT perspective: innovative applications of stereotactic body radiation therapy in metastatic castration-resistant prostate cancer

Hahn,

Aparicio,

Jadvar

et al. 2024

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

The systematic review by Guevelou et al. examines the impact of stereotactic body radiotherapy (SBRT) on patients with metastatic castration-resistant prostate cancer (mCRPC) [1]. The authors analyze 19 relevant studies, predominantly retrospective, to assess the effectiveness of SBRT in improving progression-free survival (PFS) and biochemical progression-free survival (bPFS) in individuals experiencing metachronous oligoprogression, particularly when combined with androgen receptor pathway inhibitors. They report promising outcomes, with bPFS ranging from 9.5 to 17.9 months. While SBRT is noted for its tolerability and low incidence of severe toxicity, the authors emphasize that the overall evidence remains limited, highlighting the necessity for prospective trials to establish clearer clinical guidelines.

show abstract

Update on PSMA-based Prostate Cancer Imaging

Mena,

Lindenberg,

Choyke

2024

Seminars in Nuclear Medicine

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)

Abstract: Visual Abstract

Cited by 6 publications

References 27 publications

PSMA PET/CT in staging recurrent prostate cancer: a viewfinder, not a compass

PSMA PET/CT in staging recurrent prostate cancer: a viewfinder, not a compass

MDT perspective: innovative applications of stereotactic body radiation therapy in metastatic castration-resistant prostate cancer

Update on PSMA-based Prostate Cancer Imaging

Contact Info

Product

Resources

About